11 July 2024 SCANDION ONCOLOGY’S RIGHTS ISSUE REGISTERED WITH THE DANISH BUSINESS AUTHORITY Download Presentation Webcast Workbook
1 July 2024 Scandion Oncology board member Michel Ducreux steps down, joins advisory board Download Presentation Webcast Workbook
25 June 2024 SCANDION ONCOLOGY ANNOUNCES OUTCOME OF THE RIGHTS ISSUE Download Presentation Webcast Workbook
3 June 2024 Scandion announces change of Certified Adviser to Vator Securities Download Presentation Webcast Workbook
31 May 2024 SCANDION ONCOLOGY PUBLISHES PROSPECTUS RELATING TO THE RIGHTS ISSUE Download Presentation Webcast Workbook
6 May 2024 Scandion Oncology Announces Results of Annual General Meeting and Constitution of the Board of Directors Download Presentation Webcast Workbook
19 April 2024 Scandion Oncology – Notice convening the Annual General Meeting Download Presentation Webcast Workbook
15 December 2023 Scandion Oncology identifies potentially effective treatment of gastric cancer Download Presentation Webcast Workbook
29 November 2023 Scandion Oncology is granted new Composition of Matter-patent on lead compound SCO-101 extending its exclusivity until at least 2042 Download Presentation Webcast Workbook